PFG
36
3
MET
66
3
SLB
37
-4
THC
50
2
CME
52
2
DTE
63
5
AIG
32
-3
CNX
49
7
AA
38
-2
VRTX
49
3
CTSH
46
-3
MPC
36
3
WM
54
4
KMB
28
-2
LLY
37
4
LNC
28
-2
HES
61
2
MCK
56
3
PNR
53
3
EXR
37
15
PFG
36
3
MET
66
3
SLB
37
-4
THC
50
2
CME
52
2
DTE
63
5
AIG
32
-3
CNX
49
7
AA
38
-2
VRTX
49
3
CTSH
46
-3
MPC
36
3
WM
54
4
KMB
28
-2
LLY
37
4
LNC
28
-2
HES
61
2
MCK
56
3
PNR
53
3
EXR
37
15
Financhill
Back

PIMCO Corporate & Income Strategy Fund Vs. Janux Therapeutics Industry Stock Comparison

Buy
62

PCN
PIMCO Corporate & Income Strategy Fund

Last Price:
$13.53
Seasonality Move:
-0.95%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
62
PIMCO Corporate & Income Strategy Fund (PCN) is a Buy

Is PIMCO Corporate & Income Strategy Fund a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Strategy Fund [PCN] share price is $13.54. The Score for PCN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • PCN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PCN Stock Price Chart

What is PIMCO Corporate & Income Strategy Fund's stock price today?

  • The PIMCO Corporate & Income Strategy Fund share price today is $13.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCN is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

PCN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.73 Sell
Chaikin Money Flow: 313689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.44 - 13.98) Sell
Bollinger Bands (100): (13.54 - 14.08) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

PCN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.5 Buy
20-day SMA: 13.62 Sell
50-day SMA: 13.81 Sell
200-day SMA: 13.53 Buy
8-day EMA: 13.53 Buy
20-day EMA: 13.61 Sell
50-day EMA: 13.74 Sell
200-day EMA: 13.57 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

PIMCO Corporate & Income Strategy Fund Earnings Growth & PCN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

PIMCO Corporate & Income Strategy Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):